Company's main product, medium molecular weight Hydroxyethyl Starch (HES) API, of which the dosage forms serve as plasma substitute for curing and preventing hypovolemia and shock. It won the first prize of Hubei Provincial Scientific and Technological Advances Award for its new synthesis technology of HES, and has?a number of invention patents. The products have been registered in several countries, and acquired EU CEP certificate, and have been exported to dozens foreign countries. Using the generic technology?Platform of?polysaccharide?and?protein products,?the company has?developed?a?new?peritoneal?dialysis?product, Icodextrin,?high-end iron supplement?products-?Iron?protein?succinylate,?Ferric carboxymahose?and?other?APIs, serving?hundreds?enterprises?at?home?and?abroad.